Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38


Oestradiol and leptin have separate but additive anorexigenic effects and differentially target fat mass in rats.

Côté I, Green SM, Yarrow JF, Conover CF, Toklu HZ, Morgan D, Carter CS, Tümer N, Scarpace PJ.

J Neuroendocrinol. 2018 Nov;30(11):e12646. doi: 10.1111/jne.12646.


Longitudinal Examination of Bone Loss in Male Rats After Moderate-Severe Contusion Spinal Cord Injury.

Otzel DM, Conover CF, Ye F, Phillips EG, Bassett T, Wnek RD, Flores M, Catter A, Ghosh P, Balaez A, Petusevsky J, Chen C, Gao Y, Zhang Y, Jiron JM, Bose PK, Borst SE, Wronski TJ, Aguirre JI, Yarrow JF.

Calcif Tissue Int. 2018 Sep 14. doi: 10.1007/s00223-018-0471-8. [Epub ahead of print]


Activity-Based Physical Rehabilitation with Adjuvant Testosterone to Promote Neuromuscular Recovery after Spinal Cord Injury.

Otzel DM, Lee J, Ye F, Borst SE, Yarrow JF.

Int J Mol Sci. 2018 Jun 7;19(6). pii: E1701. doi: 10.3390/ijms19061701. Review.


Cross talk between androgen and Wnt signaling potentially contributes to age-related skeletal muscle atrophy in rats.

Mumford PW, Romero MA, Mao X, Mobley CB, Kephart WC, Haun CT, Roberson PA, Young KC, Martin JS, Yarrow JF, Beck DT, Roberts MD.

J Appl Physiol (1985). 2018 Aug 1;125(2):486-494. doi: 10.1152/japplphysiol.00768.2017. Epub 2018 May 3.


Testosterone Deficiency, Weakness, and Multimorbidity in Men.

Peterson MD, Belakovskiy A, McGrath R, Yarrow JF.

Sci Rep. 2018 Apr 12;8(1):5897. doi: 10.1038/s41598-018-24347-6.


Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury.

Phillips EG, Beggs LA, Ye F, Conover CF, Beck DT, Otzel DM, Ghosh P, Bassit ACF, Borst SE, Yarrow JF.

PLoS One. 2018 Mar 26;13(3):e0194440. doi: 10.1371/journal.pone.0194440. eCollection 2018.


Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis.

Skinner JW, Otzel DM, Bowser A, Nargi D, Agarwal S, Peterson MD, Zou B, Borst SE, Yarrow JF.

J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):465-481. doi: 10.1002/jcsm.12291. Epub 2018 Mar 15.


Testosterone Plus Finasteride Prevents Bone Loss without Prostate Growth in a Rodent Spinal Cord Injury Model.

Yarrow JF, Phillips EG, Conover CF, Bassett TE, Chen C, Teurlings T, Vasconez A, Alerte J, Prock H, Jiron JM, Flores M, Aguirre JI, Borst SE, Ye F.

J Neurotrauma. 2017 Nov 1;34(21):2972-2981. doi: 10.1089/neu.2016.4814. Epub 2017 Jun 5.


High Prevalence of Low Serum Biologically Active Testosterone in Older Male Veterans.

Conover CF, Yarrow JF, Garrett TJ, Ye F, Quinlivan EP, Cannady DF, Peterson MD, Borst SE.

J Am Med Dir Assoc. 2017 Apr 1;18(4):366.e17-366.e24. doi: 10.1016/j.jamda.2016.12.077. Epub 2017 Feb 14.


Testosterone inhibits expression of lipogenic genes in visceral fat by an estrogen-dependent mechanism.

Holland AM, Roberts MD, Mumford PW, Mobley CB, Kephart WC, Conover CF, Beggs LA, Balaez A, Otzel DM, Yarrow JF, Borst SE, Beck DT.

J Appl Physiol (1985). 2016 Sep 1;121(3):792-805. doi: 10.1152/japplphysiol.00238.2016. Epub 2016 Aug 18.


Fructose consumption does not worsen bone deficits resulting from high-fat feeding in young male rats.

Yarrow JF, Toklu HZ, Balaez A, Phillips EG, Otzel DM, Chen C, Wronski TJ, Aguirre JI, Sakarya Y, Tümer N, Scarpace PJ.

Bone. 2016 Apr;85:99-106. doi: 10.1016/j.bone.2016.02.004. Epub 2016 Feb 12.


Testosterone and Adult Male Bone: Actions Independent of 5α-Reductase and Aromatase.

Yarrow JF, Wronski TJ, Borst SE.

Exerc Sport Sci Rev. 2015 Oct;43(4):222-30. doi: 10.1249/JES.0000000000000056. Review.


Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.

Borst SE, Yarrow JF.

Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1035-42. doi: 10.1152/ajpendo.00111.2015. Epub 2015 Apr 21. Review.


Review of health risks of low testosterone and testosterone administration.

Jia H, Sullivan CT, McCoy SC, Yarrow JF, Morrow M, Borst SE.

World J Clin Cases. 2015 Apr 16;3(4):338-44. doi: 10.12998/wjcc.v3.i4.338. Review.


Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.

Borst SE, Shuster JJ, Zou B, Ye F, Jia H, Wokhlu A, Yarrow JF.

BMC Med. 2014 Nov 27;12:211. doi: 10.1186/s12916-014-0211-5. Review.


Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss.

Beggs LA, Ye F, Ghosh P, Beck DT, Conover CF, Balaez A, Miller JR, Phillips EG, Zheng N, Williams AA, Aguirre JI, Wronski TJ, Bose PK, Borst SE, Yarrow JF.

J Bone Miner Res. 2015 Apr;30(4):681-9. doi: 10.1002/jbmr.2396.


Cognitive effects of testosterone and finasteride administration in older hypogonadal men.

Borst SE, Yarrow JF, Fernandez C, Conover CF, Ye F, Meuleman JR, Morrow M, Zou B, Shuster JJ.

Clin Interv Aging. 2014 Aug 12;9:1327-33. doi: 10.2147/CIA.S61760. eCollection 2014.


Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone.

Beggs LA, Yarrow JF, Conover CF, Meuleman JR, Beck DT, Morrow M, Zou B, Shuster JJ, Borst SE.

Am J Physiol Endocrinol Metab. 2014 Sep 1;307(5):E456-61. doi: 10.1152/ajpendo.00184.2014. Epub 2014 Jul 29.


Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle.

Ye F, McCoy SC, Ross HH, Bernardo JA, Beharry AW, Senf SM, Judge AR, Beck DT, Conover CF, Cannady DF, Smith BK, Yarrow JF, Borst SE.

Steroids. 2014 Sep;87:59-66. doi: 10.1016/j.steroids.2014.05.024. Epub 2014 Jun 10.


Influence of aromatase inhibition on the bone-protective effects of testosterone.

Beck DT, Yarrow JF, Beggs LA, Otzel DM, Ye F, Conover CF, Miller JR, Balaez A, Combs SM, Leeper AM, Williams AA, Lachacz SA, Zheng N, Wronski TJ, Borst SE.

J Bone Miner Res. 2014 Nov;29(11):2405-13. doi: 10.1002/jbmr.2265.

Supplemental Content

Loading ...
Support Center